CARDIOMIL
ActiveSummary
CARDIOMIL has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €472,655 and a net result of €159,387. Equity has been growing by about 58% per year since 2022. The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 20-05-2022 Normal situation
- Activity
- “L’exercice de la médecine et singulièrement la médecine spécialisée en cardiologie.” (deed in French)From the articles, 15 activitiesNo NACE code in the KBO yet
- Financial year end
- 31 December
- Peppol
- Reachable since 30-12-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €210,389
- ▲ 4.6%
- Turnover
- ≈ €540,000
- estimated
- Profit
- €159,387
- ▲ 10.5%
- Equity
- €472,655
- ▲ 50.9%
- Total assets
- €575,400
- ▲ 43.7%
Score breakdownraises riskFounded in 2022lowers riskSize: total assets €575,400Liquidity: current ratio 5.23, cash €449,158Equity €472,655 (82.1% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 86% on liquidity, 90% on profitability and 86% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 4 accounts on average 5 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
Key points
- Positive: Equity rose in 2025from €313,268 to €472,655 ▲ 50.9% View
Recent changes
- · Gazette deed IncorporationStarting capital €1,000
Key facts about CARDIOMIL
- What is the company number of CARDIOMIL?
- The company number of CARDIOMIL is 0786.438.881. The VAT number is the same number with BE in front: BE 0786.438.881.
- Where is CARDIOMIL based?
- The registered office is at d'Orbaixlaan 39, 1180 Ukkel.Company details
- What is the legal form of CARDIOMIL?
- The legal form of CARDIOMIL is Private limited company (BV).
- When was CARDIOMIL founded?
- CARDIOMIL was founded on 20-05-2022.
- Is CARDIOMIL still active?
- Yes, CARDIOMIL is an active enterprise in the KBO register.
- What is the turnover of CARDIOMIL?
- The turnover in financial year 2025 is ≈ €540,000. This figure is estimated from the gross margin of €210,389 and 1,648 comparable companies of the same size. It probably lies between €330,000 and €1.0m. It is a rough estimate.Financials
- Is CARDIOMIL profitable?
- In financial year 2025, CARDIOMIL made a profit of €159,387.
- Where can I find the annual accounts of CARDIOMIL?
- CARDIOMIL filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of CARDIOMIL due?
- CARDIOMIL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.